Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

JABIL INC (JBL)

CIK 0000898293 1 material event

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 2 sellers sold $1.4M
Open-market · last 90 days: 0 buyers bought $0 2 sellers sold $1.4M
InsiderRoleDateTransactionSharesValue
Crowley Matthew EVP, Global Business Units 2026-10-28 Open-market sell 3922 $1.1M
BORGES STEVEN D EVP, Global Business Units 2026-10-24 Tax withholding 592 $162K
BORGES STEVEN D EVP, Global Business Units 2026-10-24 Tax withholding 1889 $518K
Berry Adam E. SVP, IR and Corporate Affairs 2026-10-24 Tax withholding 147 $40K
Crowley Matthew EVP, Global Business Units 2026-10-24 Tax withholding 473 $130K
Dastoor Michael CEO, Director 2026-10-24 Tax withholding 2960 $811K
Hebard Gregory B CFO 2026-10-24 Tax withholding 652 $179K
McKay Francis SVP, Chief Procurement Officer 2026-10-24 Tax withholding 555 $152K
Melachrino Kristine EVP, General Counsel 2026-10-24 Tax withholding 591 $162K
Priestley Andrew EVP, Chief Operations Officer 2026-10-24 Tax withholding 444 $122K
Renno Rafael SVP, Global Business Units 2026-10-24 Tax withholding 189 $52K
Schick Gary K. SVP, CHRO 2026-10-24 Tax withholding 591 $162K
BORGES STEVEN D EVP, Global Business Units 2026-10-22 Grant/award 5734 $0
BORGES STEVEN D EVP, Global Business Units 2026-10-22 Grant/award 5734 $0
BORGES STEVEN D EVP, Global Business Units 2026-10-22 Grant/award 2867 $0
BORGES STEVEN D EVP, Global Business Units 2026-10-22 D 1751 $0
BORGES STEVEN D EVP, Global Business Units 2026-10-22 Tax withholding 2103 $591K
BORGES STEVEN D EVP, Global Business Units 2026-10-22 Tax withholding 3624 $1.0M
Berry Adam E. SVP, IR and Corporate Affairs 2026-10-22 Grant/award 2618 $0
Berry Adam E. SVP, IR and Corporate Affairs 2026-10-22 Grant/award 2618 $0
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2026-08-31 versus 2025-08-31 — view filing on EDGAR →

An FDA Warning Letter issued August 2026 — with manufacturing paused pending remediation — marks a concrete enforcement escalation that is the dominant risk shift this period. Compounding this, an active global memory shortage is currently constraining the supply chain, versus a resolved prior-year disruption. Together, these two simultaneous operational impairments create meaningful near-term production and revenue risk.

1 company-specific · 1 common-mode

Company-specific changes

Revised

FDA Warning Letter issued August 2026 for manufacturing/quality deficiencies; manufacturing paused pending remediation. Concrete enforcement action materially escalates regulatory risk.

We may face heightened liability risks specific to our medical device business as a result of additional healthcare regulatory related compliance requirements and the potential severe consequences…

Also disclosed — common-mode (Semiconductor supply chain constraints)
Semiconductor supply chain constraints Revised

Supply chain risk escalated: prior year referenced FY2023 shortages (past tense); current year states supply chain "is currently impacted" by global memory shortage, indicating ongoing material constraint.

Efficient component and material purchasing is critical to our manufacturing processes and contractual arrangements. A shortage of components or an increase in price could interrupt our operations…

Fiscal period ending 2025-08-31 versus 2024-08-31 — view filing on EDGAR →

Newly disclosed U.S. tariffs on aluminum, steel, and goods from Canada, Mexico, and China — alongside retaliatory measures — introduce direct cost-pass-through risk to operating results and cash flows. A separate new disclosure flags AI-tool-related confidentiality exposure as a threat to competitive position. Both additions are incremental and localized, leaving the overall risk picture modestly worse but not broadly deteriorated.

0 company-specific · 2 common-mode

Also disclosed — common-mode (Tariffs trade policy, AI cybersecurity escalation)
Tariffs trade policy Revised

New disclosure of February 2025 U.S. tariffs on aluminum, steel, Canadian, Mexican, and Chinese goods, plus retaliatory tariffs, with explicit warning that inability to pass costs could adversely impact operating results and cash flows.

We derive a substantial majority of our revenues from our international operations, which are subject to a number of different risks and often require more management time and expense than our…

AI cybersecurity escalation Revised

New AI-related cybersecurity risks disclosed: inadvertent disclosure of confidential information through third-party AI tools and training sets, threatening competitive position.

Disruptions to our information systems, including security breaches, losses of data or outages, and other security issues, have and could in the future adversely affect our operations. We rely on…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Earnings release

8-K filed 2026-06-17 confidence 98% Item 2.02

The filing discloses Jabil Inc.'s results of operations for the third fiscal quarter ended May 31, 2026, via a press release furnished as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides financial performance data essential to assessing the registrant's operational results and financial condition.

View raw filing on EDGAR →